|
|
|
|
|
|
|
|
|
|
Oak HC/FT Targets $2 Billion | Stada Revives IPO Plans
|
|
|
|
|
|
|
|
Good morning! We have a shorter-than-normal, but still interesting newsletter for you as we head into the Labor Day weekend.
I report that Oak HC/FT is back in the market targeting $2 billion to back companies in healthcare and fintech, sectors experiencing an AI bounce.
Over in Germany, Stada's plans for an initial public offering are back on. The pharmaceutical company was set to pull the trigger in April before world events got in the way. Now onto the news...
WSJ Pro Private Equity will be taking a break on Monday for the Labor Day holiday in the U.S. We'll be back on Tuesday. Have a good weekend ...
|
|
|
|
|
|
|
|
|
|
Oak HC/FT has an office in San Francisco. PHOTO: JOHN G MABANGLO/EPA-EFE/SHUTTERSTOCK
|
|
|
|
|
|
Oak HC/FT is back on the fundraising trail, about three years after closing its last flagship fund to invest in healthcare and fintech companies. The investment firm is looking to raise at least $2 billion for Oak HC/FT Partners VI, a modest increase on the $1.94 billion of commitments collected the last time around, WSJ Pro PE’s Rod James reports. Oak HC/FT is entering a tough market, with fundraising for healthcare-focused- private-equity and venture funds hitting multi-year lows in 2024. The market may be rebounding, however, as investor enthusiasm around AI grows.
|
|
|
Private-equity backed Stada aims to launch an initial public offering this fall following a postponement this past spring, joining the scattering of companies queuing up to list before year-end, Dow Jones Newswires’ Aimee Look writes. The German pharmaceutical company, which is backed by Bain Capital and Cinven, delayed plans to go public in April, citing geopolitical uncertainty and market volatility
|
|
|
|
|
|
|
|
|
$173 Billion
|
|
The value of private-equity healthcare deals during the first half of 2025, slightly below last year’s pace, according to a recent report from Bain & Co.
|
|
|
|
|
|
|
|
|
|
|
Desjardins Group's asset management arm is buying listed Guardian Capital Group. PHOTO: GRAHAM HUGHES,BLOOMBERG NEWS
|
|
|
|
|
|
Desjardins Group’s asset management arm has agreed to acquire publicly traded Guardian Capital Group in a deal that values the investment management company’s equity at $1.67 billion. Guardian had 164.1 billion Canadian dollars, or around $119.37 billion, in client assets as of June 30.
|
|
|
Newly formed growth investment firm Sundance Growth is backing TurnKey Lender, an Austin, Texas-based provider of artificial intelligence-driven lending automation technology. Sundance Growth, which was founded by former Accel-KKR dealmaker Christian Stewart, raised $125 million for its debut fund earlier this year.
|
|
|
Sycamore Partners has completed its take-private deal for Walgreens Boots Alliance. Following the deal, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD will operate as separate, standalone companies.
|
|
|
|
|
|
|
Our add-on deal interactive tool allows you to sort and analyze volumes of add-on deal data compiled by WSJ Pro. View more.
|
|
|
|
|
|
|
Capital Dynamics and Entangled Capital have sold glass vial manufacturer Alphial S.r.l. to SGD Pharma, a glass-packaging company owned by PAI Partners, according to an emailed press release. Capital Dynamics and Entangled acquired Alphial in 2024.
|
|
|
Carlyle’s recently confirmed deal for financial advice technology company Intelliflo marks the latest deal by a U.S.-based investor in the U.K. wealth management sector, sister publication Financial News reports. But the $200 million acquisition does not appear to be a great win for seller Invesco, which exited the company at a discount to what it paid seven years ago.
|
|
|
|
|
Madison Dearborn Capital Partners is seeking $3 billion for Madison Dearborn Capital Partners IX and related parallel vehicles, a regulatory filing shows. The new fund’s offering amount is a little more than half of the $5 billion that the firm raised for the fund’s predecessor.
|
|
|
Menlo Ventures is seeking $700 million for Menlo Ventures XVII and another $800 million for Menlo Inflection IV, according to regulatory filings. The Menlo Park, Calif.-based venture firm amassed a total of $1.35 billion back in 2023 for two predecessor funds. The firm’s Inflection strategy was formed to back promising startups that are beyond the seed or early stage of their life cycle, but have yet to reach the larger growth stage.
|
|
|
Sycamore Tree Capital Partners has raised $505 million for upsized collateralized loan obligation, STCP 2025-7, to invest in broadly syndicated loans of U.S. companies. International investors represented around 25% of the CLO’s debt.
|
|
|
|
|
New York-based merchant bank Relay Capital Group has formed a partnership with MENA Growth Partners to connect U.S. technology and venture capital funds with investors in the Middle East.
|
|
|
|
|
|
|
|
|
|
|
|
